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Abstract
Background: Urinary tract infections (UTIs) are one of the most common infections found in humans, with
uropathogenic Escherichia coli (UPEC) being the most common cause. Prevention of UTI is a major global concern
due to its recurrent nature, medical cost, and most importantly, the increased antimicrobial resistance among UPEC.
The resistance in UPEC is mainly due to the Extended-Spectrum β-lactamases (ESBL), particularly the E. coli CTXM-15
type which is known for its rapid dissemination worldwide. Treatment options for E. coli CTXM-15 have become
limited over recent years because of their multi-drug resistance, hence anti-virulent strategies based on herbal
remedies, have considered as a viable option. The cranberry product, Cysticlean® capsules, contain 240 mg of
proanthocyanins (PACs), which have been shown to significantly inhibit E. coli adherence, both in vitro and ex vivo,
to uroepithelial cells.
Method: In this study, the cephalosporin-resistant E. coli isolate NCTC 1553 (E. coli CTXM-15) was analysed by qRT-
PCR (quantitative Reverse Transcriptase -Polymerase Chain Reaction) for the expression of virulence factors after
treatment with Cysticlean®. qRT-PCR was carried out to detect virulence determinants encoding for toxins SAT, and
USP, the iron acquisition system ChuA, the protectins SoxS, KPSM, TraT and RecA, the antibiotic resistance gene
CTX-M (encode β-lactamases), and the transporters IdfB and HcaT.
Results: Cysticlean® significantly reduced the expression of all ten selected genes encoding for virulence factors
and β-lactamases.
Conclusion: Cranberry product Cysticlean® could represent a practicable alternative option for the prevention of
recurrent UTI caused by multi-drug resistant E. coli CTXM-15, as the product acts on multiple bacterial targets.
Keywords: Urinary tract infections; virulence, Uropathogenic Escherichia coli, UPEC, E. coli CTXM-15, Cranberry,
Proanthocyanins (PACs)
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Introduction
Urinary tract infections (UTIs) are among the most
common infectious disease affecting humans and have
been estimated to occur in at least 50% of women at
some stage during their lives. They are responsible for
more than 7 million visits to physicians annually and
15% of all prescribed antibiotics in the US and European
countries [1]. Because of the highly prevalent nature of
UTIs, they represent a public health and economic bur-
den. In the United States, in 2010, the annual direct and
indirect cost of UTIs was estimated at $2.3 billion [2],
and in the UK it has been estimated that the NHS has
spent £434 million in 2013/14 to treat UTIs [3]; simi-
larly, many other countries also incurred high medical
costs in dealing with this common infection [2].
UTI are caused mainly by Uropathogenic E. coli (UPEC),
which accounts for approximately 80% of all UTIs [4].
Common symptoms include painful, frequent and urgent
need to urinate and can lead to irreversible kidney damage
and even death [5]. Adjunctive treatment of UTI and
prevention of recurrent UTI has become a global concern
due to associated morbidity and increased medical cost
associated with this infection [6]. UPEC associated with
high levels of ESBL gene carriage [7] and the CTX-M β-
lactamase family is the predominant ESBL type in many
countries. Within this family, CTX-M-15 considered the
most prevalent genotype worldwide [8]. It was demon-
strated that CTX-M-15 is associated with an extensive
pattern of antimicrobial resistance to a large number of an-
tibiotics such as penicillins, cephalosporins, monobactams,
and carbapenem [9]. Moreover, CTX-M-producing UPEC
also exhibits coresistance to other large antimicrobial fam-
ilies such as aminoglycosides and fluoroquinolones [9].
Hence, this increasing level of UPEC multi-drug resistance
is a great health and economic concern as it limits the
therapeutic options available for the treatment of common
bacterial infections such as UTIs.
In 2018, the World Health Organisation (WHO) com-
posed a global priority list of antibiotic resistant bacteria
and categorised the third-generation cephalosporin-
resistant Enterobacteriaceae, as a global priority one group
of pathogens, that needed urgent research and develop-
ment of novel antibiotics [10]. CTX-M-producing UPEC
belongs to the third-generation cephalosporin-resistant
Enterobacteriaceae family, highlighted the importance of
development of novel antibiotic for UTI associated with
this pathogen. As a part of the therapeutic strategies de-
signed to combat antimicrobial resistance among the UTI
pathogens, the use of alternative methods such as anti-
virulence strategies, which manipulates virulence factors
of the bacteria rather than bacterial growth factors, are
considered an effective tool as they have a lower risk of
resistance development [11]. It is thought that the main
reason for UPEC being so successful is their expression of
a wide range of virulence factors [4]. Virulence genes are
commonly located on mobile genetic elements such as
pathogenicity islands, transposons, bacteriophages or plas-
mids and are generally spread by DNA horizontal transfer
[12]. Understanding the role of virulence factors and their
expression enables research that aims to discover novel
therapeutic mechanisms that can limit bacterial infection.
Virulence factors important to UPEC infection of the
urinary tract include adhesins, capsules, toxins and iron-
acquisition systems [12]. These virulence factors contrib-
ute to the colonization and invasion of the urinary tract,
leading to biofilm formation, tissue damage and ascension
to the bladder and kidneys. Research suggests that adhe-
sins, or fimbriae, are the most important determinant of
virulence in the infection of the urinary tract and have
therefore been studied extensively.
It has been demonstrated that cranberries can decrease
the virulence of UPEC, however little work has been
completed on virulence factors other than for adhesins.
Many in vivo and in vitro results have shown a significant
inhibition of the adherence of E. coli to uroepithelial cells
[13, 14]. A significant improvement in symptoms has been
seen, including the reduction in painful, frequent and
urgent urination [15]. Most of the above studies were
focused on considering the cranberries as a whole fruit
than its active compound, PACs, hence for this study the
cranberry capsule Cysticlean® was chosen, which contains
240mg of PACs. This study focusses on the toxins SAT,
and USP, the iron acquisition system ChuA, the protectins
SoxS, KPSM, TraT and RecA, the antibiotic resistance
gene CTX-M and the genes responsible for the normal
function of the cell, IdfB and HcaT. In this study, the
CTX-M producing E. coli isolate NCTC 1553 was ana-
lysed via qRT-PCR for the expression of virulence factors,
both before and after treatment with the cranberry prod-
uct Cysticlean®. The results reported herein show that
cranberry treatment reduces the expression of multiple
virulence factors. These data suggest that cranberry’s
mechanism may be multifaceted.
Materials and methods
Bacterial isolate and cranberry capsules
Escherichia coli isolate NCTC 13353 (anti-microbial re-
sistance resistant reference strain from Public Health
England, UK) expressing the resistance gene CTX-M-15
was used in all parts of this study. Cysticlean® capsules
were purchased from VITA GREEN Europe S. A, which
contained 240 mg of PACs per capsule.
Minimum inhibitory concentration
In order to determine the concentration of cranberry re-
quired for use in the RT-qPCR experiment, the minimum
inhibitory concentration was determined using the broth
macro dilution method in triplicates. A 60mg/ml PAC
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stock solution in 20ml minimal medium (M9 Minimal
Salts, 5X, Sigma Aldrich, Dorset, UK) was used for serial di-
lutions of the following concentrations of Cysticlean®: 30,
15, 7.5, 3.75, 1.88, 0.94, 0.47, 0.23, 0.12, 0.059, 0.029mg/ml.
An overnight culture (108 CFU/ml) of E. coli NCTC 1553
was diluted to 0.5 McFarland standard in minimal medium,
and 100 μl of this diluted culture was added to each con-
centration. Cultures were incubated at 37 °C with shaking
overnight. The MIC was determined as the lowest concen-
tration with no visible growth. A positive control, consisting
of minimal medium and E. coli, and a negative control,
consisting of minimal medium only, were included.
RNA extraction
A 10ml volume of the MIC concentration was prepared
in minimal medium. An overnight culture of E. coli NCTC
1553 was diluted to 0.5 McFarland standard, 100 μl of
which was added to the cranberry solution and incubated
with shaking at 37 °C for 4 h. A second untreated culture
was also incubated as an untreated control. A negative
control consisting of minimal medium only was also in-
cluded. All cultures were then filtered with a Whatman 1
and 0.45 membrane (GE Healthcare Life Sciences, Buck-
inghamshire, UK) before RNA lysate was extracted using
the Cells-to-CT™ 1-Step TaqMan™ Kit (ThermoFisher Sci-
entific, Loughborough, UK) following the manufacturer’s
instructions, with the exception that the lysis + DNase
time was doubled to 10min. RNA concentration was mea-
sured using a Qubit 3 fluorometer (ThermoFisher Scien-
tific, Paisley, UK). The quality of RNA and the presence of
any DNA was assessed using agarose gel electrophoresis.
Design of primers and probes for reverse transcriptase
qPCR (RT-qPCR)
Primers and Taqman probes were designed using the Pri-
merQuest Tool (Integrated DNA Technologies) using the
custom design parameters listed in Table 1. Primers were
designed to be 20–24 bp, with a melting temperature of
approximately 60 °C. The GC content was designed to be
40–60. Taqman probes were designed to be 20–30 bp in
length, with a melting temperature of 7–10 °C higher than
that of the primers, and with a GC content of 35–65%.
The OligoAnalyzer 3.1 (Integrated DNA Technologies
Inc., Illinois, USA, https://eu.idtdna.com/calc/analyzer)
was used to identify and possibility of any secondary struc-
ture and primer dimers. Whilst non-specific products do
not produce results in Taqman qPCR, and were avoided
because they reduce the efficiency of the reaction. The
FAM fluorophore was added to the 5′ end of the probe
and the Black Hole Quencher®-1 was added to the 3′ end
using the custom DNA oligo tool (Integrated DNA Tech-
nologies). Probes were ordered on a 100 nm scale and
purified by high performance liquid chromatography
(HPLC). Primers were ordered on a 25 nm scale by stand-
ard methods. Both primers and probes were ordered as
“lab ready”, 100 μM in IDTE, PH 8.0.
Primer specificity
RT-qPCR primers were checked for specificity by end-
point PCR using extracted DNA, as presented in Fig. 1.
Cycling parameters were as follows: initial denaturation
at 95°C for 20 s, followed by 40 cycles of 95 °C for 15 s
each and 60 °C for 1 min.
Primer efficiencies
Primer efficiencies were calculated using serial dilutions
of amplicons (diluted 1:1000) in triplicate and by plot-
ting the resulting data to produce standard curves for
each primer pair selected. The amplification efficiency =
[10(−1/slope)] – 1. A correlation coefficient (R2) of 0.99
or greater was considered. An amplification efficiency of
Table 1 Sequences of primers and probes used in this study
Forward Reverse Probe Amplicon size (bp) Reference
16 s GGAGACTGCCAGTGATAAA GAGGTCGCTTCTCTTTGT CCTTACGACCAGGGCTACACACGT 113 This study
kpsM GTTATATGGGACCGTCATATT GCCACACTCTTTCGTATC CCCAGAGCTTGCGGATTATCAATC 125 This study
chuA CGATGGGCGAAATGTATAA GTTAGTTTCCGGACGTAAG TCTCGATTGGTCGCTTCTATACCA 98 This study
CTX-M GAAAGCGAACCGAATCT GACATCGTCCCATTGAC ACCTTGTTAACTATAATCCGATTGCGG 101 This study
sat AGAAATATGGCATCTGTCACC CAGACGATATAGTCGGTGTTTC CAGCAACCATTACTCTGGGACAGC 97 This study
usp TGAGTTCTGGTATGAGGAAGA CCCGTATGAACACCATACAC TACTGCCTGCTAGTGCTTTCTGCC 126 This study
soxS AGGGTTGATTACCAGTATCC AACATATCGCAACACATCAC ACAGCGGCAATCAGCGGCGATATA 70 This study
recA GAGACAATTTGGTACTCCATC GATATCCAGTGAAAGCGAAC CGCCTGGGTGAAGACCGTTCCAT 90 This study
traT AGATTGCAGAGCGTACTAAG ACACGGGTCTGGTATTTATG CAACGGATAATGTTGCCGCCCTGC 127 This study
ihfB GACGGTTGAAGATGCAGTAA CGGTAGTGCAAAGAGAAACT AGCATATGGCCTCGACTCTTGCGC 108 This study
hcaT GGCATTATGGGAGCAACTAC CTGGCGAGCAGCAATATAAC ACCACTATCAACCACGGCAACGCC 114 This study
Primer and probe sets were designed using the PrimerQuest Tool (Integrated DNA Technologies). All probes contained a FAM fluorophore at the 5′ end and a
black hole quencher at the 3′ end.
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80–120% was considered and the efficiencies of selected
primers are presented in Table 2.
RT-qPCR method
The Cells-to-CT™ 1-Step TaqMan™ Kit was used for RT-
qPCR. This kit allows for expression analysis from cultured
cells without the requirement for extensive RNA purifica-
tion. The mastermix contains a reverse transcriptase,
allowing for a 1-step RT-qPCR. The Cells-to-CT™ master-
mix contained the reverse transcriptase and allowed cDNA
conversion during qPCR. qPCR reactions were carried out
using the PikoReal® 96 well real-time PCR platform (Ther-
moFisher, Loughborough, UK). PCR amplification reac-
tions were performed using three technical replicates, in a
volume of 10 μl containing 2.5 μl TaqMan® 1-Step qRT-
PCR Mix (initial concentration not known), with final
concentrations of 500 nM primers, 250 nM probe and 1 μl
of RNA lysate. Cycling parameters for the RT-qPCR assay
were, an initial reverse transcription step at 50 °C for
5min, reverse transcriptase inactivation/initial denatur-
ation at 95 °C for 20 s, followed by 40 cycles of 95 °C for
15 s and, finally, 60 °C for 1min. A no-reverse transcript-
ase control was implemented in triplicate by adding the
mastermix containing reverse transcriptase after the
reverse transcription step of the RT-qPCR assay. A no
template control consisting of water instead of RNA was
also added in triplicate. The experiment was performed
twice (using two biological replicates) and the representa-
tive values presented were the means of the triplicates.
Statistical analysis
Quantification cycle (Cq) values were obtained after com-
pletion of the RT-qPCR. The relative abundance of the tar-
get gene in each sample (treated) and calibrator (untreated)
was calculated using the Cq value of the internal reference
gene 16SrRNA as a control and the relative expression level
of the target gene = 2-ΔΔCq (where ΔCq =Cq(target gene) -
Cq(reference gene), and ΔΔCq =ΔCq(test) - ΔCq(calibrator)) as de-
scribed previously [16], with a modification to account for
primer efficiencies using Microsoft Excel. Primer efficien-
cies were calculated using serial dilutions of amplicons
(diluted 1:1000), and this efficiency was also used in the
ΔΔCt calculations. All statistical analyses were carried out
using the GraphPad Prism software (version 5; GraphPad
Software Inc.; La Jolla, CA, USA). To determine the signifi-
cant differences between treated and untreated samples,
the t-test was performed. A difference with a p-value
of <0.05 was considered statistically significant.
Results
Mic
The MIC for E. coli strain NCTC 13353 was deter-
mined to be 15 mg/ml, and this was used in all subse-
quent experiments.
Fig. 1 The specificity of each primer pair investigated by qRT-PCR for this study. End amplified products of qPCR were visualised using agarose
gel electrophoresis. All genes were detected at the expected bp size and single band was observed for each primer pair indicating primer
specificity. M, Molecular Weight marker, GeneRuler 50 bp DNA Ladder (Thermofisher, UK). Products and ladder ran on 4% Agarose gel.
Table 2 The efficiencies of the primers used in the
development of the RT-qPCR study
Primer Efficiency %
16S (reference gene) 84.3
recA 111.1
CTX-M 99.7
sat 111.6
traT 94.3
chuA 115.6
kpsM 101.7
soxS 103.0
usp 90.2
hcaT 118.9
IhfB 115.3
Primer efficiencies were calculated using serial dilutions of amplicons 1:1000.
An efficiency of 80–120% was considered.
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RT-qPCR
In this study, RT-qPCR was used to evaluate the impact of
exposure of E. coli NCTC 13353 cells to the commercial
cranberry product Cysticlean® (at MIC; for 4 h) on the
expression of ten genes that have been shown to be associ-
ated with the virulence of UPEC. The selected genes
included the toxins SAT and USP, the iron acquisition
system ChuA, the protectins SoxS, KPSM, TraT and
RecA, the antibiotic resistance gene CTX-M, and the
genes responsible for the normal function of the cell, IdfB
and HcaT. Figure 2 shows the mean average Ct values as a
measure of expression of these 10 genes in the absence or
presence of cranberry treatment. There was a significant
decrease (P < 0.05) in the Ct value for each gene in the
presence of cranberry, indicating a decrease in expression.
Figure 3 shows the decrease as a Double Delta Ct Value
(ΔΔCt) -1. By presenting the data as (ΔΔCt) -1, a value of
0 would indicate no change while a value between 0 and 1
indicates a downregulation in expression. The t-test
showed that all the genes tested were significantly down-
regulated (P < 0.05) following treatment with cranberry.
It is not possible to run melting curve analyses on
Taqman assays due to the degenerative nature of
Taqman probes. Non-specific products do not produce
results in Taqman assays; therefore, it is not necessary to
run products on an agarose gel; however, non-specific
products should in any case be avoided because they re-
duce the efficiency of the reaction. Taqman assays were
checked for specificity before running qPCR.
Discussion
Reports have shown that numerous genes are implicated in
the virulence and fitness of UPEC, therefore downregulating
the expression of these genes could add to the effi-
ciency of antibiotic treatment and could reduce the
likelihood of treatment failure [17]. In this study, the
selected ten genes playing significant roles in the nor-
mal function of the cell, such as iron acquisition, toxin
production and stress survival in the third-generation
cephalosporin resistant E. coli, and their relative gene
expression was determined after exposure to the cran-
berry product Cysticlean® using qRT-PCR. The results
showed that Cysticlean® significantly reduces the
expression of a wide variety of genes responsible for
fitness and virulence. To the best of our knowledge,
this is the first study to access the effect PACs, the
active compound of the cranberry on the expression of
virulence and antibiotic resistance determinants. A
reported mechanism of action the selected genes is
represented in Fig. 4.
Reports have suggested that USP functions as a
bacteriocin, targeting competing bacterial strains
(depicted in Fig. 4). It has also been shown to enhance
infectivity in the urinary tract and play a role in UPEC
pathogenesis [18, 19]. In a study by Bauer et al. [20], it
was shown that the usp gene was found in 80% of cyst-
itis isolates [20]. A reduction in the expression of usp
could lead to this bacterium being outcompeted by
other non-pathogenic bacteria and a reduction in its
ability to cause pyelonephritis. It is especially advanta-
geous for UPEC to be able to utilize haem and/or
haemoglobin, as the urinary tract is naturally low in
iron. UPEC secrete cytotoxins that can access the
haem reservoir within cells. These two capacities com-
bined could aid iron acquisition throughout the infec-
tion process [20, 21]. ChuA is an outer membrane
Fig. 2 Ct values as a measure of expression of the selected virulence genes. Genes for toxin production, iron acquisition, antibiotic resistance
protectins and normal function of the cell were tested after exposure to Cysticlean® using RT-qPCR all genes were significantly downregulated
when tested using a t-test. * p = 0.01 to 0.05 ** p = 0.001 to 0.01 *** p = < 0.001 ns = not significant
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receptor responsible for the transport of haem into the
cell for utilization as iron (see Fig. 4) [22]. A reduction
in iron transport into the cell could lead to reduced
growth of the bacteria, or potentially even cell death.
In a study, cranberry treatment resulted in the up-
regulation of genes that encode iron metabolism regu-
lators (fur), transport protein (feoAB), genes involved
in the biogenesis pathway of Fe-S clusters (iscAS) and
iron storage (ftnA, acnA, sodB) [13]. This is the first
study to investigate the expression of the chuA gene
after exposure to a cranberry product. Combining the
literature with the results of this study, cranberry can
be said to cause the overexpression of iron-acquisition
genes, but a downregulation of haem membrane recep-
tors. It has been suggested that the expression of chuA
is influenced by RfaH in UPEC [22]. Therefore, it may
be that Cysticlean® has an effect on RfaH that requires
further investigation.
SAT is a serine protease which is found predominantly
in uropathogenic strains of E. coli, and which has been
shown to elicit a cytopathic effect on cultured epithelial
cells (see Fig. 4); it has also been shown to be associated
with pyelonephritis [13]. A reduction in the expression
of sat gene could lead to a reduction in the ability of
UPEC to cause pyelonephritis. KpsM is responsible for
capsule production, protecting the bacterial cell from
host defenses such as engulfment by phagocytes and the
bactericidal effects produced by the complement system
(see Fig. 4). KpsM is commonly associated with pyelo-
nephritis [13]. A downregulation in the expression of
kpsM gene could lead to cell death by phagocytes and
the complement system.
SoxS increases tolerance to stress, as activated by cyto-
toxic weapons produced by the human immune system
such as nitric oxide, and leads to direct activation of
antibiotic resistance factors [23]. Reduction in the
expression of soxS could lead to bacteria that are less
tolerant to stress and generally less antibiotic resistant.
In a study, cranberry treatment caused significant over-
expression of genes involved in the stress response
(arcA, rpoS, cpxR), periplasmic stress (rseAC) and oxida-
tive stress (oxyR). This being said, they did not specific-
ally report results on the soxS [23]. RecA plays a role in
DNA recombination by catalysing the homologous
pairing driven by ATP and the strand exchange of DNA
molecules (Fig. 4) [24]. A reduction in recombinational
repair could lead to bacteria that are less able to survive.
TraT is an outer membrane lipoprotein that is
responsible for preventing unproductive conjugation
between bacteria carrying like plasmids (Fig. 4). It has
also been shown to interfere with complement-
mediated killing, imparting a mild amount of serum
resistance [21]. A downregulation in the expression of
traT gene could lead to an increase in unproductive
conjugation and a decrease in serum resistance. The
hcaT gene plays a role in the catabolism of 3-
phenylpropionate and cinnamic acid, the products of
which are fed into the mhp pathway (see Fig. 4-III).
IhfB is responsible for the activation of transcription
via sequence-specific DNA binding and for site-
specific recombination. It is uncommon to see changes
in expression of these genes; indeed, they have been
recommended as suitable reference genes in transcrip-
tional analysis of E. coli [25]. Even though it was the
least downregulated gene, it could be stipulated that
the most important downregulation was that of the
CTX-M gene that causes extended-spectrum β-
lactamase (ESBL) production. ESBL-producing UTIs
Fig. 3 The expression fold change of genes antibiotic resistance, iron acquisition, toxins, protections and genes responsible for the normal
function of the cell. The results of the expression fold change were normalized against the reference gene 16 s and then were taken away from
one to show the genes were downregulated
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are a major problem in both the community and the
hospital. Hence the results indicated that the reduction
in the expression of CTX-M gene could lead to the in-
creased susceptibility of other known resistant isolates.
This study suggests that the effects of Cysticlean® are
multifactorial, effecting many different pathways. Other
studies have shown that exposure of UPEC to cranberry
PACs or cranberry powder results in the downregulation of
the flagellin gene fliC, which results in impeded motility via
swimming and swarming. Honey has also been shown to
have a similar effect on virulence genes, though its ability to
reach the urinary tract intact has been questioned [26].
Based on above literature and current findings, two
complementary mechanisms have been suggested to ex-
plain the ability of the American cranberry to reduce
urinary tract infections. The first mechanism has been
credited to its biocidal activity, as enabled through the
production of several elements that can damage bacteria.
The second mechanism is attributed to its anti-virulence
activity, through the downregulation and interference
with multiple virulence factors associated with tolerance
to stress and survival in the urinary tract. The latter
could ultimately result in the weakening of bacterial sur-
vival abilities and its ability to cause infection [27].
Fig. 4 Reported mechanisms of action for 10 Virulence genes in Escherichia coli are downregulated by cranberry treatment. This study has shown
that the following a selection of 10 genes, which encode for virulence factors with different mechanisms, were all downregulated when exposed
for Cysticlean® for 4 h at MIC. 1) uropathogenic specific protein gene (usp) encode for bacteriocin that possesses DNase activity that can degrade
plasmid DNA of competing uropathogens. 2) chuA encodes for outer membrane protein that plays a key role in heme uptake. 3) hcaT encodes
for permease for the uptake of phenylpropionic acid (PP), an aromatic acid that can be utilised as a carbon and energy source. 4) kpsM encodes
for protein that plays a role in group 2 capsular polysaccharide synthesis. 5) ihfB encodes for specific DNA-binding protein that functions in
genetic recombination as well as in transcriptional and translational control. 6) recA encodes for protein that catalysise ATP-driven homologous
pairing and strand exchange of DNA molecules necessary for DNA recombinational repair. 7) soxS encode for a transcriptional activator of the
superoxide response regulon of E. coli. 8) traT encodes for protein that prevents unproductive conjugation between bacteria carrying like
plasmids. 9) CTX-M produces beta-lactamases that can render beta-lactams inactive. 10) sat encode for a secreted autotransporter toxin exhibits
cytopathic activity and loosening of cellular junctions. These data suggested that cranberry’s antimicrobial action is multifaceted
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Recurrent UTI is commonly treated with antibiotic
prophylaxis, which has been attributed to bacterial re-
sistance. Antibiotic resistance is a major concern
worldwide, therefore a re-evaluation of the treatment
recommendations for UTI should be considered. An
alternative to antibiotic prophylaxis could be treatment
using cranberry products or a combination of cran-
berry and antibiotic treatment in an attempt to reduce
resistance rates in UTIs.
Future studies into analysing the effects of the active
compound PACs on other virulence and antibiotic re-
sistance determinants and in other bacterial species
that cause UTI need to be carried out. This should in-
volve testing other virulence and antibiotic resistance
genes; a microarray analysis may be more useful in this
regard. Moreover, these analyses also be combined
with phenotypic and in vivo studies to give a broad
overview of the effects that cranberry treatment has.
Other bacterial strains and species, as well those that
are antibiotic resistant and non-resistant, that cause
UTI should be studied to see if the effect of cranberry is
broad-spectrum in nature. In this study, only one refer-
ence gene could be used. Multiple reference genes in-
crease the accuracy of relative expression normalization
and allow for appropriate quality control on the stability
of the reference gene expression. Therefore, the use of
one reference gene represents a particular limitation to
this study.
Conclusions
Taken together, the study showed that the cranberry
active compound PACs has effective downregulation
activity on the fitness, virulence and antibiotic resist-
ance in the ESBL producing E. coli strain CTX-M 15,
which is the most common bacterial pathogen associ-
ated with UTIs and that shows multi-drug-resistant
abilities. Hence, the study results indicated the cran-
berry compound PACs may represent a promising
anti-virulence strategy for the treatment and modula-
tion of the UTIs caused by E. coli strain CTX-M 15.
Based on the results of this study, PAC can be used as
co adjunctive method to reduce antibiotic resistance
rates in recurrent Urinary Tract Infection.
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